{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,19]],"date-time":"2026-01-19T02:32:29Z","timestamp":1768789949028,"version":"3.49.0"},"reference-count":40,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2004,4,1]],"date-time":"2004-04-01T00:00:00Z","timestamp":1080777600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2004,4,1]],"date-time":"2004-04-01T00:00:00Z","timestamp":1080777600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["jpet.aspetjournals.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Journal of Pharmacology and Experimental Therapeutics"],"published-print":{"date-parts":[[2004,4]]},"DOI":"10.1124\/jpet.103.060061","type":"journal-article","created":{"date-parts":[[2004,3,26]],"date-time":"2004-03-26T18:07:46Z","timestamp":1080324466000},"page":"432-438","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":40,"title":["Novel 2\u2032,6\u2032-Dimethyl-l-Tyrosine-Containing Pyrazinone Opioid Mimetic \u03bc-Agonists with Potent Antinociceptive Activity in Mice"],"prefix":"10.1016","volume":"309","author":[{"given":"Yunden","family":"Jinsmaa","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yoshio","family":"Okada","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuko","family":"Tsuda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kimitaka","family":"Shiotani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yusuke","family":"Sasaki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Akihiro","family":"Ambo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sharon D.","family":"Bryant","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lawrence H.","family":"Lazarus","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1124\/jpet.103.060061_bib1","doi-asserted-by":"crossref","unstructured":"Balboni G, Salvadori S, Guerrini R, Negri L, Giannini E, Jinsmaa Y, Bryant SD, and Lazarus LH (2002) Potent \u03b4-opioid receptor agonists containing the Dmt-Tic pharmacophore. J Med Chem 45: 5556-5563.","DOI":"10.1021\/jm020336e"},{"key":"10.1124\/jpet.103.060061_bib2","doi-asserted-by":"crossref","unstructured":"Banks WA and Kastin AJ (1990) Peptide transport systems for opiates across the blood-brain barrier. Am J Physiol 259: E1-E10.","DOI":"10.1152\/ajpendo.1990.259.1.E1"},{"key":"10.1124\/jpet.103.060061_bib3","doi-asserted-by":"crossref","unstructured":"Bodnar RJ, Williams CL, Lee SJ, and Pasternak GW (1988) Role of mu 1-opiate receptors in supraspinal opiate analgesia: a microinjection study. Brain Res 447: 25-34.","DOI":"10.1016\/0006-8993(88)90962-6"},{"key":"10.1124\/jpet.103.060061_bib4","doi-asserted-by":"crossref","unstructured":"Bryant SD, Jinsmaa Y, Salvadori S, Okada Y, and Lazarus LH (2003) Dmt and opioid peptides: a potent alliance. Biopolymers (Peptide Sci) 71: 86-102.","DOI":"10.1002\/bip.10399"},{"key":"10.1124\/jpet.103.060061_bib5","doi-asserted-by":"crossref","unstructured":"Bryant SD, Salvadori S, Cooper PS, and Lazarus LH (1998) New \u03b4-opioid antagonists as pharmacological probes. Trends Pharmacol Sci 19: 42-46.","DOI":"10.1016\/S0165-6147(97)01156-5"},{"key":"10.1124\/jpet.103.060061_bib6","doi-asserted-by":"crossref","unstructured":"Chandrakumar NS, Stapelfeld A, Beardsley PM, Lopez OT, Drury B, Anthony E, Savage MA, Williamson LN, and Reichman M (1992) Analogs of the delta opioid receptor selective cyclic peptide [2-D-penicillamine,5-D-penicillamine]-enkephalin: 2\u2032,6\u2032-dimethyltyrosine and Gly3-Phe4 amide bond isostere substitutions. J Med Chem 32: 2928-2938.","DOI":"10.1021\/jm00094a002"},{"key":"10.1124\/jpet.103.060061_bib7","doi-asserted-by":"crossref","unstructured":"Dygos JH, Yonan EE, Scaros MG, Goodmonson OJ, Getman DP, Periana RA, and Beck GR (1992) A convenient asymmetric synthesis of the unnatural amino acid 2,6-dimethyl-L-tyrosine. Synthesis 8: 741-743.","DOI":"10.1055\/s-1992-26212"},{"key":"10.1124\/jpet.103.060061_bib8","doi-asserted-by":"crossref","unstructured":"Ermisch A, Brust P, Kretzschmar R, and Ruhle HJ (1993) Peptides and blood-brain barrier transport. Physiol Rev 73: 489-527.","DOI":"10.1152\/physrev.1993.73.3.489"},{"key":"10.1124\/jpet.103.060061_bib9","doi-asserted-by":"crossref","unstructured":"Goodman RR and Pasternak GW (1985) Visualization of mu1 opiate receptors in rat brain by using a computerized autoradiographic subtraction technique. Proc Natl Acad Sci USA 82: 6667-6671.","DOI":"10.1073\/pnas.82.19.6667"},{"key":"10.1124\/jpet.103.060061_bib10","doi-asserted-by":"crossref","unstructured":"Guerrini R, Capasso A, Sorrentino L, Anacardio R, Bryant SD, Lazarus LH, Attila M, and Salvadori S (1996) Opioid receptor selectivity alteration by single residue replacement: synthesis and activity profile of [Dmt1]deltorphin B. Eur J Pharmacol 302: 37-42.","DOI":"10.1016\/0014-2999(96)00067-2"},{"key":"10.1124\/jpet.103.060061_bib11","doi-asserted-by":"crossref","unstructured":"Hansen JDW, Stapelfeld A, Savage MA, Reichman M, Hammond DL, Haaseth RC, and Mosberg HI (1992) Systemic analgesic activity and delta-opioid selectivity in [2,6-dimethyl-Tyr1, D-Pen2,D-Pen5]enkephalin. J Med Chem 35: 684-687.","DOI":"10.1021\/jm00082a008"},{"key":"10.1124\/jpet.103.060061_bib12","doi-asserted-by":"crossref","unstructured":"Heyman JS, Mulvaney SA, Mosberg HI, and Porreca F (1987) Opioid delta-receptor involvement in supraspinal and spinal antinociception in mice. Brain Res 420: 100-108.","DOI":"10.1016\/0006-8993(87)90244-7"},{"key":"10.1124\/jpet.103.060061_bib13","doi-asserted-by":"crossref","unstructured":"Heyman JS, Williams CL, Burks TF, Mosberg HI, and Porreca F (1988) Dissociation of opioid antinociception and central gastrointestinal propulsion in the mouse: studies with naloxonazine. J Pharmacol Exp Ther 245: 238-243.","DOI":"10.1016\/S0022-3565(25)22285-6"},{"key":"10.1124\/jpet.103.060061_bib14","doi-asserted-by":"crossref","unstructured":"Hughes J, Smith TW, Kosterlitz HW, Fothergill LA, Morgan BA, and Morris HR (1975) Identification of two related pentapeptides from the brain with potent opiate agonist activity. Nature (Lond) 258: 577-580.","DOI":"10.1038\/258577a0"},{"key":"10.1124\/jpet.103.060061_bib15","doi-asserted-by":"crossref","unstructured":"Laursen SE and Belknap JK (1986) Intracerebroventricular injections in mice. J Pharmacol Methods 16: 355-357.","DOI":"10.1016\/0160-5402(86)90038-0"},{"key":"10.1124\/jpet.103.060061_bib16","doi-asserted-by":"crossref","unstructured":"Ling GS and Pasternak GW (1983) Spinal and supraspinal opioid analgesia in the mouse: the role of subpopulations of opioid binding sites. Brain Res 271: 152-156.","DOI":"10.1016\/0006-8993(83)91376-8"},{"key":"10.1124\/jpet.103.060061_bib17","doi-asserted-by":"crossref","unstructured":"Ling GS, Simantov R, Clark JA, and Pasternak GW (1986) Naloxonazine actions in vivo. Eur J Pharmacol 129: 33-38.","DOI":"10.1016\/0014-2999(86)90333-X"},{"key":"10.1124\/jpet.103.060061_bib18","doi-asserted-by":"crossref","unstructured":"Moskowitz AS and Goodman RR (1985a) Autoradiographic distribution of mu1 and mu2 opioid binding in the mouse central nervous system. Brain Res 360: 117-129.","DOI":"10.1016\/0006-8993(85)91227-2"},{"key":"10.1124\/jpet.103.060061_bib19","doi-asserted-by":"crossref","unstructured":"Moskowitz AS and Goodman RR (1985b) Autoradiographic analysis of mu1, mu2 and delta opioid binding in the central nervous system of C57BL\/6BY and CXBK (opioid receptor-deficient) mice. Brain Res 360: 108-116.","DOI":"10.1016\/0006-8993(85)91226-0"},{"key":"10.1124\/jpet.103.060061_bib20","doi-asserted-by":"crossref","unstructured":"Narita M, Imai S, Itou Y, Yajima Y, and Suzuki T (2002) Possible involvement of m1-opioid receptors in the fentanyl- or morphine-induced antinociception at supraspinal and spinal sites. Life Sci 70: 2341-2354.","DOI":"10.1016\/S0024-3205(01)01550-8"},{"key":"10.1124\/jpet.103.060061_bib21","doi-asserted-by":"crossref","unstructured":"Nishimura SL, Recht LD, and Pasternak GW (1984) Biochemical characterization of high-affinity 3H-opioid binding. Further evidence for Mu1 sites. Mol Pharmacol 25: 29-37.","DOI":"10.1016\/S0026-895X(25)14967-5"},{"key":"10.1124\/jpet.103.060061_bib22","doi-asserted-by":"crossref","unstructured":"Okada Y, Fukumizu A, Takahasi M, Yokoi T, Tsuda Y, Bryant SD, and Lazarus LH (1999) Synthesis of pyrazinone ring-containing opioid mimetics and examination of their opioid receptor binding activity. Chem Pharm Bull (Tokyo) 47: 1193-1195.","DOI":"10.1248\/cpb.47.1193"},{"key":"10.1124\/jpet.103.060061_bib23","doi-asserted-by":"crossref","unstructured":"Okada Y, Tsuda Y, Fujita Y, Yokoi T, Sasaki Y, Ambo A, Konishi R, Nagata M, Salvadori S, Jinsmaa Y, et al. (2003) Unique high-affinity synthetic mu-opioid receptor agonists with central- and systemic-mediated analgesia. J Med Chem 46: 3201-3209.","DOI":"10.1021\/jm020459z"},{"key":"10.1124\/jpet.103.060061_bib24","doi-asserted-by":"crossref","unstructured":"Okada Y, Tsukatani M, Taguchi H, Yokoi T, Bryant SD, and Lazarus LH (1998) Amino acids and peptides. LII. Design and synthesis of opioid mimetics containing a pyrazinone ring and examination of their opioid receptor binding activity. Chem Pharm Bull (Tokyo) 46: 1374-1382.","DOI":"10.1248\/cpb.46.1374"},{"key":"10.1124\/jpet.103.060061_bib25","doi-asserted-by":"crossref","unstructured":"Pasternak GW and Wood PJ (1986) Multiple mu opiate receptors. Life Sci 38: 1889-1898.","DOI":"10.1016\/0024-3205(86)90217-1"},{"key":"10.1124\/jpet.103.060061_bib26","doi-asserted-by":"crossref","unstructured":"Paul D, Bodnar RJ, Gistrak MA, and Pasternak GW (1989) Different mu receptor subtypes mediate spinal and supraspinal analgesia in mice. Eur J Pharmacol 168: 307-314.","DOI":"10.1016\/0014-2999(89)90792-9"},{"key":"10.1124\/jpet.103.060061_bib27","doi-asserted-by":"crossref","unstructured":"Porreca F, Mosberg HI, Hurst R, Hruby VJ, and Burks TF (1984) Roles of mu, delta and kappa opioid receptors in spinal and supraspinal mediation of gastrointestinal transit effects and hot-plate analgesia in the mouse. J Pharmacol Exp Ther 230: 341-348.","DOI":"10.1016\/S0022-3565(25)21481-1"},{"key":"10.1124\/jpet.103.060061_bib28","doi-asserted-by":"crossref","unstructured":"Portoghese PS, Sultana M, and Takemori AE (1988) Naltrindole, a highly selective and potent non-peptide delta opioid receptor antagonist. Eur J Pharmacol 146: 185-186.","DOI":"10.1016\/0014-2999(88)90502-X"},{"key":"10.1124\/jpet.103.060061_bib29","doi-asserted-by":"crossref","unstructured":"Pitzele BS, Hamilton RW, Kudla KD, Tsymbalov S, Stapelfeld A, Savage MA, Clare M, Hammond DL, and Hansen DW Jr (1994) Enkephalin analogs as systemically active antinociceptive agents: O- and N-alkylated derivatives of the dipeptide amide L-2,6-dimethyltyrosyl-N-(3-phenylpropyl)-D-alaninamide. J Med Chem 37: 888-896.","DOI":"10.1021\/jm00033a005"},{"key":"10.1124\/jpet.103.060061_bib30","doi-asserted-by":"crossref","unstructured":"Rossi GC, Brown GP, Leventhal L, Yang K, and Pasternak GW (1996) Novel receptor mechanisms for heroin and morphine-6 \u03b2-glucuronide analgesia. Neurosci Lett 216: 1-4.","DOI":"10.1016\/0304-3940(96)12976-1"},{"key":"10.1124\/jpet.103.060061_bib31","doi-asserted-by":"crossref","unstructured":"Salvadori S, Balboni G, Guerrini R, Tomatis R, Bianchi C, Bryant SD, Cooper PS, and Lazarus LH (1997) Evolution of the Dmt-Tic pharmacophore: N-terminal methylated derivatives with extraordinary delta opioid antagonist activity. J Med Chem 40: 3100-3108.","DOI":"10.1021\/jm9607663"},{"key":"10.1124\/jpet.103.060061_bib32","doi-asserted-by":"crossref","unstructured":"Salvadori S, Guerrini R, Balboni G, Bianchi C, Bryant SD, Cooper PS, and Lazarus LH (1999) Further studies on the Dmt-Tic pharmacophore: hydrophobic substituents at the C-terminus endow delta antagonists to manifest mu agonism or mu antagonism. J Med Chem 42: 5010-5019.","DOI":"10.1021\/jm990165m"},{"key":"10.1124\/jpet.103.060061_bib33","doi-asserted-by":"crossref","unstructured":"Samii A, Bickel U, Stroth U, and Pardridge WM (1994) Blood-brain barrier transport of neuropeptides: analysis with a metabolically stable dermorphin analogue. Am J Physiol 267: E124-E131.","DOI":"10.1152\/ajpendo.1994.267.1.E124"},{"key":"10.1124\/jpet.103.060061_bib34","doi-asserted-by":"crossref","unstructured":"Sasaki Y, Suto T, Ambo A, Ouchi H, and Yamamoto Y (1999) Biological properties of opioid peptides replacing Tyr at position 1 by 2,6-dimethyl-Tyr. Chem Pharm Bull (Tokyo) 47: 1506-1509.","DOI":"10.1248\/cpb.47.1506"},{"key":"10.1124\/jpet.103.060061_bib35","doi-asserted-by":"crossref","unstructured":"Sawynok J, Pinsky C, and LaBella FS (1979) On the specificity of naloxone as an opiate antagonist. Life Sci 25: 1621-1632.","DOI":"10.1016\/0024-3205(79)90403-X"},{"key":"10.1124\/jpet.103.060061_bib36","doi-asserted-by":"crossref","unstructured":"Schiller PW, Nguyen TM, Berezowska I, Dupuis S, Weltrowska G, Chung NN, and Lemieux C (2000) Synthesis and in vitro opioid activity profiles of DALDA analogues. Eur J Med Chem 35: 895-901.","DOI":"10.1016\/S0223-5234(00)01171-5"},{"key":"10.1124\/jpet.103.060061_bib37","doi-asserted-by":"crossref","unstructured":"Smith PL, Wall DA, Gochoco CH, and Wilson G (1992) Routes of delivery: case studies. Oral absorption of peptides and proteins. Adv Drug Delivery Rev 8: 253-290.","DOI":"10.1016\/0169-409X(92)90005-B"},{"key":"10.1124\/jpet.103.060061_bib38","doi-asserted-by":"crossref","unstructured":"Wolozin BL and Pasternak GW (1981) Classification of multiple morphine and enkephalin binding sites in the central nervous system. Proc Natl Acad Sci USA 78: 6181-6185.","DOI":"10.1073\/pnas.78.10.6181"},{"key":"10.1124\/jpet.103.060061_bib39","doi-asserted-by":"crossref","unstructured":"Yaksh TL, Kohl RL, and Rudy TA (1977) Induction of tolerance and withdrawal in rats receiving morphine in the spinal subarachnoid space. Eur J Pharmacol 42: 275-284.","DOI":"10.1016\/0014-2999(77)90294-1"},{"key":"10.1124\/jpet.103.060061_bib40","doi-asserted-by":"crossref","unstructured":"Zadina JE, Hackler L, Ge LJ, and Kastin AJ (1997) A potent and selective endogenous agonist for the mu-opiate receptor. Nature (Lond) 386: 499-502.","DOI":"10.1038\/386499a0"}],"container-title":["The Journal of Pharmacology and Experimental Therapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022356524312923?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022356524312923?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1124\/jpet.103.060061","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,19]],"date-time":"2025-02-19T20:51:13Z","timestamp":1739998273000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022356524312923"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2004,4]]},"references-count":40,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2004,4]]}},"alternative-id":["S0022356524312923"],"URL":"https:\/\/doi.org\/10.1124\/jpet.103.060061","relation":{},"ISSN":["0022-3565"],"issn-type":[{"value":"0022-3565","type":"print"}],"subject":[],"published":{"date-parts":[[2004,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Novel 2\u2032,6\u2032-Dimethyl-l-Tyrosine-Containing Pyrazinone Opioid Mimetic \u03bc-Agonists with Potent Antinociceptive Activity in Mice","name":"articletitle","label":"Article Title"},{"value":"The Journal of Pharmacology and Experimental Therapeutics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1124\/jpet.103.060061","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2004 The American Society for Pharmacology and Experimental Therapeutics","name":"copyright","label":"Copyright"}]}}